IN2013MU02046A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02046A
IN2013MU02046A IN2046MU2013A IN2013MU02046A IN 2013MU02046 A IN2013MU02046 A IN 2013MU02046A IN 2046MU2013 A IN2046MU2013 A IN 2046MU2013A IN 2013MU02046 A IN2013MU02046 A IN 2013MU02046A
Authority
IN
India
Prior art keywords
mscs
relates
treating
diabetes
isolation
Prior art date
Application number
Inventor
Satish Mahadeorao Totey
Manoj Kumar C Reddy
Lyle Carl Fonseca
Shashank Gowda
Aarya HARI
Basavaraj Chougule
Minita Sodhi
Original Assignee
Kasiak Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kasiak Res Pvt Ltd filed Critical Kasiak Res Pvt Ltd
Priority to IN2046MU2013 priority Critical patent/IN2013MU02046A/en
Priority to PCT/IN2013/000584 priority patent/WO2014203269A2/en
Publication of IN2013MU02046A publication Critical patent/IN2013MU02046A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for isolation, purification and industrial scale expansion of canine adipose tissue derived mesenchymal stem cells (MSCs). The invention also relates to a method for treating and a therapeutic product for treating osteoarthritis, spinal cord injury, atopic dermatitis, dilated cardiomyopathy, type-1 diabetes, renal failure, hepatic disease and nonhealing wounds comprising MSCs.
IN2046MU2013 2013-06-17 2013-09-26 IN2013MU02046A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN2046MU2013 IN2013MU02046A (en) 2013-06-17 2013-09-26
PCT/IN2013/000584 WO2014203269A2 (en) 2013-06-17 2013-09-26 Method for isolation, purification and industrial scale expansion of canine adipose tissue derived mesenchymal stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2046MU2013 IN2013MU02046A (en) 2013-06-17 2013-09-26

Publications (1)

Publication Number Publication Date
IN2013MU02046A true IN2013MU02046A (en) 2015-06-05

Family

ID=52105424

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2046MU2013 IN2013MU02046A (en) 2013-06-17 2013-09-26

Country Status (2)

Country Link
IN (1) IN2013MU02046A (en)
WO (1) WO2014203269A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP1500218A2 (en) * 2015-05-08 2016-11-28 Deltabio 2000 Kft Method and composition for treatment of orthopedic diseases articular cortilage injuries and particularly to dysphoria
CN105132500A (en) * 2015-08-31 2015-12-09 李青峰 SVF (stromal vascular fraction) preparation method
CN105238748A (en) * 2015-10-27 2016-01-13 上海百众源生物科技有限公司 Preparation method of placenta-source decidua parietalis mesenchymal stem cells by separation and refrigeration
CN105685015B (en) * 2016-03-10 2018-11-27 广州赛莱拉干细胞科技股份有限公司 A kind of cells frozen storing liquid
CN107746829B (en) * 2017-10-19 2022-03-22 佛山科学技术学院 Method for separating and primary culturing dog placenta-derived mesenchymal stem cells
EP3720948A1 (en) 2018-03-12 2020-10-14 Universidade do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
EP3875097B1 (en) * 2018-06-15 2023-06-07 NextPhase Therapeutics, Inc. Pharmaceutical composition for dermatology and uses thereof
CN111621469A (en) * 2020-06-01 2020-09-04 重庆医科大学 Technology for separating osteocyte by improved enzyme digestion method and application thereof
EP4366748A1 (en) * 2021-07-08 2024-05-15 Boehringer Ingelheim Veterinary Medicine Belgium Mesenchymal stem cells for use in the treatment of atopic dermatitis
CN113774020B (en) * 2021-08-24 2023-04-14 河北朋和生物科技有限公司 Construction method of adipose-derived mesenchymal stem cell bank
BR102022016233A2 (en) * 2022-08-16 2024-02-27 Omics Biotecnologia Animal Ltda CONCENTRATE OF PROTEINS AND PEPTIDES DERIVED FROM MESENCHYMAL STROMA CELLS, METHOD OF OBTAINING AND USE OF CONCENTRATE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1996013A4 (en) * 2005-09-21 2010-03-10 Dask Technologies Llc Methods and compositions for organ and tissue functionality
EP2486930B1 (en) * 2009-10-06 2016-03-23 National University Corporation Nagoya University Cell preparation containing adipose tissue derived mesenchymal stem cells for use in the treatment of a condition of no urge to urinate
WO2011064733A1 (en) * 2009-11-27 2011-06-03 Stempeutics Research Pvt. Ltd. Methods of preparing mesenchymal stem cells, compositions and kit thereof
US8962331B2 (en) * 2010-02-01 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors
WO2013070765A1 (en) * 2011-11-09 2013-05-16 Allocure, Inc. Assay for the prediction of therapeutic effectiveness or potency of mesenchymal stem cells, and methods of using same

Also Published As

Publication number Publication date
WO2014203269A2 (en) 2014-12-24
WO2014203269A3 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
IN2013MU02046A (en)
IN2013MU02045A (en)
BR112013030492A2 (en) method of producing a fabric product, fabric product produced by a process, treatment method, and treatment system
BR112014029655A2 (en) tissue preparation device, and method for preparing tissue
PE20170931A1 (en) NEW STANDARDS AND MEDICAL DEVICES FOR THE PREPARATION OF PLASMA RICH IN PLATELETS (PRP) OR BONE MARROW CONCENTRATE (BMC) ALONE OR COMBINED WITH HYALURONIC ACID
EP3022216C0 (en) Improved process for the organosolv treatment of lignocellulosic biomass
MX2015009613A (en) Process for preparing strained fermented dairy product.
PL3686211T3 (en) Process for efficient purification of neutral human milk oligosaccharides (hmos) from microbial fermentation
MX2022004300A (en) Composition and method for diagnosis and treatment of diseases associated with neurite degeneration.
BR112015023472A2 (en) method of production of a chemical, method of bioproduction of a chemical, genetically modified organism and product
BR122021023230B8 (en) Combination vaccine comprising a vaccine comprising a live attenuated parvovirus
BR112015006393A2 (en) method for producing a fabric product, fabric product produced by a process, and treatment method
MX2015015188A (en) Novel cloning, expression & purification method for the preparation of ranibizumab.
BR112016030758B8 (en) USE OF MULTIPOTENT STROME CELLS DERIVED FROM MESENCHYMAL ADIPOSE TISSUE
ES2666382T8 (en) Active orthosis for the neurological rehabilitation of the movement of the lower limbs, system comprising said orthosis and process for putting said system into operation
EP2970052A4 (en) PROCESS TO MANUFACTURE 2-CHLORO-1,1,1,2-TETRAFLUOROPROPANE (HCFC-244bb)
MX2015008944A (en) Lyophilization process.
FI20126067A (en) Method and equipment for treatment of the substance classified as waste, product produced by the method and use of the product
BR112016002462A2 (en) Methods To Improve Asthma Symptoms Using Benralizumab
BR112016002317A2 (en) methods to increase forced expiratory volume in asthmatics using benralizumab
IN2013MU02047A (en)
SG10202010615QA (en) Method for promoting and improving properties of adipose tissue, tissue and cells obtained by said method
FR3009555B1 (en) PROCESS FOR THE PREPARATION OF ORGANIC PEROXIDES
BR112017018574A2 (en) methods for treating diseases
AR090964A1 (en) PROCESS FOR THE PREPARATION OF CYCLE UNDECAPEPTIDES